EMJ 6.2 2021

In this issue

 

Volume 6, Issue 2
Contents
Symposium review
12-17 Pioneering Best Practices in Atopic Dermatitis: Results from the Quality of Care Initiative Guttman
Poster review
19-23 Late-Breaking Abstracts: Health Status Benefits of Mavacamten in Obstructive Hypertrophic Cardiomyopathy and the Modifying Effect of Ejection Fraction on the Therapeutic Benefit of Omecamtiv Mecarbil in Heart Failure Spertus and Teerlink
Articles
25-35 Editor’s Pick: Relating Ventilatory Support and Drug Treatment Strategies to the Fundamental Pathophysiology in COVID-19 Illness Lewis et al.
37-46 Understanding the Impact of Non-Dystrophic Myotonia on Patients and Caregivers: Results from a Burden of Disease Healthcare Survey Diaz-Manera et al.
47-53 Oxy-hydrogen Gas: The Rationale Behind Its Use as a Novel and Sustainable Treatment for COVID-19 and Other Respiratory Diseases Russell et al.
54-62 Prevalence of Scoliosis in Hypermobile Ehlers-Danlos Syndrome Gillas et al.
63-69 Musculoskeletal Brucellosis in Adults in the United Arab Emirates: A Retrospective Study Nokhatha et al.
70-80 Prevalence of Thromboembolic Complications in COVID-19 Infection: A Systematic Review and Meta-Analysis Pergola et al.
82-89 Prevalence of Scoliosis in Hypermobile Ehlers-Danlos Syndrome Risueno et al.
90-95 Improvements and Shortcomings in Emergency Oxygen Prescribing: A Quality Improvement Initiative at an Acute Tertiary Care Hospital Ranjbar and Dorai.
96-100 Prominent Cutaneous Manifestation of COVID-19: A Case Report Galván-Casas et al.
101-110 Pretransplant Determinants of Outcome in Patients with Myeloma Undergoing Autologous Transplantation in Lower Resource Settings Nair
111-117 Rifampicin-Induced Thrombocytopenia: A Case Report and Short Review of the Literature Koumpis et al

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.